Status:
COMPLETED
Effectiveness of Convalescent Immune Plasma Therapy
Lead Sponsor:
Bagcilar Training and Research Hospital
Conditions:
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the safety, improvement of clinical symptoms and laboratory parameters of convalescent immune plasma treatment in severe Covid-19 patients with ARDS.
Detailed Description
The aim of the study is to evaluate the safety, improvement of clinical symptoms with hypoxemia, metabolic and laboratory parameters of patients with convalescent immune plasma treatment in severe Cov...
Eligibility Criteria
Inclusion
- Inclusion Criteria Clinical diagnosis of Covid-19
- Exclusion Criteria Age lower than 18 Lower plasma IgA levels PaO2/FiO2 higher than 300 mmHg SpO2 higher than 90
Exclusion
Key Trial Info
Start Date :
May 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04442958
Start Date
May 15 2020
End Date
June 17 2020
Last Update
July 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Bagcılar Training and Research Hospital
Istanbul, Turkey (Türkiye), 34375